HYPERLIQUID STRATEGIES INC (PURR)

NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-11-04

$9.69-4.63%

Close 2026-11-04 · 1-day change

Investment OutlookAs of Nov 4, 2026

What could strengthen or challenge HYPERLIQUID STRATEGIES INC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

Matching fiscal periods, usable estimates and at least one analyst are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for PURR yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Share buyback program execution	The company has a $30 million share buyback program supporting shareholder value.	Intact	Buyback program is cancelled or materially reduced	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS improves toward breakeven	A primary condition in HYPERLIQUID STRATEGIES INC's published investment case. The stated target is EPS >= -0.50 next quarter.	Recovered	EPS remains below -0.90 next quarter	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue holds near $5.6 million	Revenue is expected near $5.6 million next quarter despite losses.	Intact	Revenue falls below $5.5 million next quarter	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-06-30 · fmp

FY2028 EPS$0.60

$0.60 → $0.60 · observed estimates

FY2028 revenue$0.07B

$0.07B → $0.07B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-23	$0.60	$72,637,000	1 / 2
2026-10-24	$0.60	$72,637,000	1 / 2
2026-10-25	$0.60	$72,637,000	1 / 2
2026-10-26	$0.60	$72,637,000	1 / 2
2026-10-27	$0.60	$72,637,000	1 / 2
2026-10-28	$0.60	$72,637,000	1 / 2
2026-10-29	$0.60	$72,637,000	1 / 2
2026-10-30	$0.60	$72,637,000	1 / 2
2026-10-31	$0.60	$72,637,000	1 / 2
2026-11-01	$0.60	$72,637,000	1 / 2
2026-11-02	$0.60	$72,637,000	1 / 2
2026-11-03	$0.60	$72,637,000	1 / 2
2026-11-04	$0.60	$72,637,000	1 / 2

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-06-01	3	0	0
2026-07-01	3	0	0
2026-08-01	3	0	0
2026-09-01	4	0	0
2026-10-01	4	0	0
2026-11-01	4	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Oct 6–Nov 4 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Share buyback program executionDirect metric needs a verified mapping
EPS improves toward breakevenDirect metric needs a verified mapping
Revenue holds near $5.6 millionDirect metric needs a verified mapping

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.5%Typical daily move · historical

Downside history

-45.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

HYPERLIQUID STRATEGIES INC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 31, 2026

What kind of bet this is

PURR is a speculative, execution-dependent financial-sector business with exposure to HYPE tokens and staking revenue. The long-term thesis is still unclear: confidence is low, and available financial history is not enough to judge the direction of performance.

What's priced into HYPERLIQUID STRATEGIES INC

The latest valuation label is inexpensive, but the evidence does not show what expectations are built into that assessment or how PURR compares with peers. Fragility is rated low, though that does not resolve the limited evidence behind the valuation view.

What the fundamentals likely do

Management has reported larger HYPE holdings, staking revenue and validator commissions, and prior share repurchases. The periods provided are not directly comparable, and the expanded repurchase authorization has no reported follow-on purchases in the available disclosures. Near term, erratic earnings surprises and a missed latest quarter make the next results worth watching.

What HYPERLIQUID STRATEGIES INC hinges on

The multi-year thesis hinges on whether treasury expansion and staking activity translate into sustained, comparable financial results, and whether management follows through on the expanded repurchase authorization. Near term, rate changes and earnings results from financial-sector bellwethers could affect the sector backdrop; evidence about PURR’s own sensitivity is limited.

Bottom line

Over the next 1 to 3 years, PURR remains an uncertain, execution-dependent thesis, with some management actions demonstrated but too little comparable performance evidence to establish a clear fundamental trend. Not investment advice.

Development preview · refreshed Nov 5, 2026Open Living FV detail

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.